Meghmani Organics Q1 FY27: Revenue Down 12% to ₹523 Cr, Profit Up 42% to ₹58 Cr
Meghmani Organics Limited reported Q1 FY27 revenue of ₹523 crore (down 12% YoY) and a net profit of ₹58 crore (up 42% YoY). EBITDA grew 16% to ₹94 crore. The company noted softer demand but improved profitability through operational efficiencies and product mix optimization. Titanium dioxide operations remain suspended.
The results show mixed performance with revenue decline but strong profit growth. The suspension of titanium dioxide operations and subdued demand in certain segments present challenges, while growth in Crop Protection and Crop Nutrition segments offers positive outlook.
Despite a revenue decline due to market conditions, the company reported a significant increase in net profit and EBITDA, indicating improved operational efficiency and profitability management.
Meghmani Organics Limited (MOL) reported its Q1 FY27 financial results, with revenue standing at nearly ₹523 crore, a 12% year-on-year decrease. However, net profit for the quarter saw a significant increase of 42% year-on-year, reaching approximately ₹58 crore, and EBITDA grew by 16% to ₹94 crore.
The company operated in a challenging business environment marked by softer demand in export and domestic markets, leading to cautious customer buying behavior and subdued off-take. Despite these conditions, MOL focused on optimizing its product mix, disciplined pricing strategies, and operational efficiencies, which contributed to the improved profitability.
In terms of segment performance, the Crop Protection segment constituted about 75% of the revenue, with production at 8,880 metric tons and capacity utilization at 63%. This segment reported revenue of ₹391 crore and EBITDA of ₹77.8 crore, with an EBITDA margin of 19.9%.
The Pigment segment accounted for 25% of the revenue, with production at 3,233 metric tons and capacity utilization at 39%. It reported revenue of ₹131 crore and EBITDA of ₹15.9 crore, achieving an EBITDA margin of 12.1%.
MOL's Crop Nutrition segment showed positive contribution, strengthened by newly introduced nano fertilizer products like Nano DAP, Nano NPK, and Nano Zinc. The company is optimistic about the long-term growth prospects of this business.
Operations in the titanium dioxide segment remained suspended due to unviable commercial conditions arising from elevated raw material costs and weaker price realization following the withdrawal of anti-dumping duty. The company reported a negative EBITDA of approximately ₹3 crore from this segment in Q1 FY27.
On a consolidated basis, revenue was nearly ₹542 crore, down by 12%. Net profit grew by 280% year-on-year to ₹48.2 crore, and EBITDA increased by 46% to ₹97.9 crore, with consolidated EBITDA margin at 18%.
As of June 30, 2026, standalone total debt was ₹555 crore (₹474 crore short-term, ₹81 crore long-term), with a debt-to-equity ratio of 0.31. Consolidated total debt stood at ₹732 crore (₹477 crore short-term, ₹256 crore long-term), with a debt-to-equity ratio of 0.46. The company made a debt repayment of approximately ₹32 crore in Q1 FY27.
Management expressed confidence in long-term growth prospects due to state-of-the-art infrastructure, diversified product portfolio, and strong geographic presence, despite near-term macroeconomic uncertainties. The company expects double-digit growth in the Crop Protection segment's top line and healthy improvement in its bottom line, while the Pigment segment is expected to generate revenues between ₹500-600 crore annually with an EBITDA margin of around 10%. The Crop Nutrition segment, with its expanding range of nano-fertilizers, is also projected to contribute significantly.
What to do with a filing like this
Meghmani Organics Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Meghmani Organics Limited. Read the original for the full detail.